Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TripSitter Clinic Ltd C.KETA

Alternate Symbol(s):  TSTTF

TripSitter Clinic Ltd. is a Canada-based company. The Company has no active business.


CSE:KETA - Post by User

Post by XeniaTechieon Jan 04, 2022 3:23pm
116 Views
Post# 34282792

2022 will be the year ketamine therapies make the mainstream

2022 will be the year ketamine therapies make the mainstream

Mark my words - 2022 will see Ketamine assisted therapies hit the mainstream. A recent study is reporting a single or multiple dose of ketamine resulted in moderate to large reductions in suicidal thoughts and depression. It’s a staggering improvement that can be observed within hours of the treatment. At only $0.22 this is such a hot time to get in on TripSitter an mHealth company connecting patients with at-home ketamine treatments.  https://www.studyfinds.org/ketamine-reduces-depression-suicidal-thoughts-within-hours/ 

 

 
<< Previous
Bullboard Posts
Next >>